baber/WOPTO huggingface dataset:
Patent EP-1083446-B1 (EP)
Title: Ligne de transmission optique, fibre optique a dispersion negative a cet effet, et systeme de transmission optique ainsi pourvu
Inventor: MUKASA KAZUNORI
IPC: H04B10/25
Filed: 2000-02-22
Granted: 2009-09-23
Abstract: La présente invention concerne une ligne de transmission optique à faible non-linéarité présentant une faible dispersion en bande L (1570-1620 nm) tout en permettant un multiplexage des longueurs d'ondes optiques dans la bande des 1520-1620 nm conventionnellement exploitée. Cette ligne de transmission réunit des blocs résultant chacun du montage en série d'un amplificateur optique (32), d'une fibre mono-mode (33), et d'un L-RDF (34) entre un émetteur optique (31) et un récepteur optique (35). La fibre mono-mode (33) est affectée d'un coefficient de dispersion positif pour un gradient de dispersion positif dans la bande définie de longueurs d'ondes de la bande L. Le L-RDF (34) est une fibre optique à coefficient de dispersion négatif de type linéaire venant corriger la dispersion ainsi que le gradient de dispersion dans la bande définie de longueurs d'ondes de la fibre mono-mode (33). Cette fibre mono-mode (33) et le L-RDF (34) étant connectés, le coefficient de dispersion dans la bande définie de longueurs d'ondes est de -1 à 1 ps/nm/km pour toute la longueur de la ligne de transmission optique.
Patent EP-1165831-B1 (EP)
Inventor: RAMBACH ALAIN
IPC: C12Q1/14
Filed: 2000-03-09
Granted: 2006-05-31
Abstract: The invention concerns a novel chromogenic medium for isolating Staphylococcus aureus, charcterised in that it comprises in a culture medium of Staphyloccus aureus at least one of the following two chromogenic agents: 5-bromo 6-chloro 3-indoxyl phosphate and 5-brono 4-chloro 3-indoxyl glucoside and it further contains deferoxamine.
Patent EP-1156754-B1 (EP)
Inventor: DIASTI ADAM
IPC: A61C13/00
Filed: 2000-02-23
Granted: 2007-10-10
Abstract: In summary, the invention is directed to a method of making a new dental prosthesis from an existing dental prosthesis, including the steps of making a sacrificial positive or pattern of the existing dental prosthesis, and using the sacrificial pattern of the existing dental prosthesis to form a new dental prosthesis. The inventive method likewise includes making a sacrificial pattern of at least a part of an existing denture. The invention further includes the construction of new dentures from a patient's worn dentures, by providing copy or modified copy of the worn dentures into which one can set and arrange the denture teeth. The invention still further includes a dental prosthetic, such as a denture, made by such methods.
Patent EP-1166051-B1 (EP)
Title: Debimetre-masse a effet coriolis de dimensions reduites
Inventor: CRISFIELD MATTHEW T
IPC: G01F1/84
Filed: 2000-03-15
Granted: 2004-07-14
Abstract: L'invention porte sur un détecteur (10) de débimètre-masse à effet Coriolis à saillant réduit. Pour réduire le saillant (c.-à-d. la longueur dont la boucle des tubes d'écoulement dépasse du pipeline), il est nécessaire que la totalité de la longueur des tubes (103A-103B) d'écoulement du détecteur entre en vibration pour rendre le détecteur plus sensible à la force de Coriolis. Quand la totalité de la longueur vibre, un premier ensemble de brides (122-123) de maintien est monté sur les tubes de manière à en (103A-103B) séparer les fréquences de vibration. Un deuxième ensemble de brides (120-121) de maintien monté sur les tubes d'écoulement renforce la stabilité du zéro du débitmètre.
Patent EP-1177681-B1 (EP)
Inventor: HANNUKSELA MISKA
IPC: H04W28/02
Filed: 2000-04-26
Granted: 2010-01-13
Abstract: A data transmission system (10) is provided for transmitting a data signal between a server (12, 14, 16, 18) and a communications terminal (20, 22) over a transmission link having a variable bandwidth. The data signal is a scalable compressed multimedia clip comprising a sequence of images. Each image has a base layer and a number of enhancement layers. To cope with variability in the bandwidth, the sequence is re-ordered so that the base layers have greater safety times than the enhancement layers. This allows all of the base layers to arrive in time to be played at the expense of the enhancement layers.
Patent EP-1165182-B1 (EP)
Inventor: RUCHALA KENNETH J
IPC: G21K5/10
Filed: 2000-03-29
Granted: 2005-03-02
Abstract: Reduced dose megavoltage CT images are obtained using low flux data resulting from leakage through modulating shutters and/or collected by other means and augmented by incomplete high flux data collected during radiation therapy. The ability to construct tomographic projection sets from significantly varying flux rate data is provided by the use of air scans windowed to account for variations in mechanical leaf movement. These methods are also provide a means of imaging the patient entirely during radiation therapy treatments without any additional scan time.
Patent EP-1083839-B1 (EP)
Inventor: DE JUAN EUGENE JR
IPC: A61B18/18
Filed: 2000-04-07
Granted: 2010-06-09
Abstract: A microsurgical laser probe is provided with a distal end portion of an optic fiber that projects from a tubular sleeve of the probe and can be caused to bend relative to the probe sleeve by manual manipulation of a mechanism on a handle of the probe.
Patent EP-1176971-B1 (EP)
Title: Use of phyllanthus for treating chronic inflammatory and fibrotic processes
Inventor: WAGNER HILDEBERT
IPC: A23L1/30
Filed: 2000-04-28
Granted: 2004-09-08
Abstract: The present invention relates to the use of Phyllanthus for preventing or treating connective tissue proliferations, for maintaining the level of reduced glutathione, for inhibiting lipopolysaccharide (LPS)-induced nitric oxide synthase (NOS) and for inhibiting expression of the cyclooxygenase (COX-2) protein.
Patent EP-1197036-B1 (EP)
Inventor: SOLALA ERKKI
IPC: H04L29/08
Filed: 2000-06-07
Granted: 2003-11-26
Abstract: The invention relates to a gateway server for receiving a message from a terminal and comprising a protocol stack ( 50 ) for processing the message according to a particular protocol stack. The server further comprises license control means ( 53 ) for controlling the access right of the message to enter the server before the message is allowed to pass to the protocol stack ( 50 ). The invention also relates to a method and a computer program product for controlling, at a server, access right of a message received from a terminal at the server.
Patent EP-1189900-B1 (EP)
Inventor: TAKAKI KATHERINE S
IPC: A61K31/402
Filed: 2000-06-06
Granted: 2004-01-14
Abstract: There is provided a novel series of heterocyclic aminopyrrolidine compounds of Formula Iwherein R1, R2, R3, R4, W, Z and the wavy bond <CUSTOM-CHARACTER FILE="US06211225-20010403-P00001.TIF" ID="CUSTOM-CHARACTER-00001"> are as defined herein which bind to the human melatonin receptor and therefore are useful as melatonergic agents.
Patent EP-1192757-B1 (EP)
Inventor: ALA-LAURILA JUHA
IPC: H04L12/28
Filed: 2000-06-28
Granted: 2009-01-21
Abstract: Apparatus, and an associated method, for identifying whether a mobile terminal and access point of a WLAN (wireless local area network) are capable of operation pursuant to a proprietary communication mode. If a determination is made that the communication pair is capable of operation pursuant to the proprietary communication mode, the mobile terminal is instructed to operate pursuant to the proprietary communication mode. Handover procedures are also provided by which better to assure that ongoing communications, during and subsequent to handover shall also be effectuated pursuant to the proprietary communication mode. Improved communication quality when the communication pair is operated pursuant to the proprietary communication mode relative to operation pursuant to a conventional IEEE 802.11 communication mode is possible.
Patent EP-1196784-B1 (EP)
Inventor: VITALONE VINCENZO
IPC: G01N33/493
Filed: 2000-07-14
Granted: 2003-09-17
Abstract: A screening-type process for the quantitative determination of cocaine and other alkaloids which are present in a solid sample and a reagent for use in the process. The process includes the steps of providing a solid sample in a finely divided or powdered form; completely immersing the sample into a liquid reagent providing a constant concentration of hydroxyl groups; maintaining the sample immersed in the liquid at a temperature in a range from 10 to 250 DEG C for a period of time in a range from a few seconds to 48 hours; and analyzing the liquid separated from the solid with a conventional kit for the determination of the said substances in urine. The reagent is a liquid that provides a constant concentration of hydroxyl groups in the range of from 0.04 to 0.33 M and comprises 0.2 M (NH4)2HPO4 with the addition of 5 ml of 25 % NH4OH for each liter thereof.
Patent EP-1207167-B1 (EP)
Inventor: SASAKI YASUHIRO
IPC: C07K7/00
Filed: 2000-06-29
Granted: 2006-10-04
Abstract: A process for the preparation of LH-RH derivatives, characterized by subjecting a solution of an LH-RH derivative to both treatment with a synthetic methacrylic resin adsorbent and that with a synthetic aromatic resin adsorbent. According to this process, the formation of by-product impurities including racemates of LH-RH derivatives can be suppressed and such impurities can be effectively removed, which enables the production of LH-RH derivatives having extremely high quality. Further, the process attains satisfactory purification effectively through the two treatment steps and can give LH-RH derivatives efficiently in high yields by easy operations not involving troublesome solid-liquid separation.
Patent EP-1198249-B1 (EP)
Inventor: GARCON NATHALIE
IPC: C07K14/16
Filed: 2000-06-28
Granted: 2005-10-19
Abstract: A vaccine formulation for the prevention or amelioration of HIV infection in humans is provided. The vaccine comprises an HIV antigen, especially a protein which comprises Nef and/or Tat of HIV, and an immunostimulatory CpG oligonucleotide. Methods for making the vaccine formulation of the invention are described. Patients may also be treated by pre-administration of the CpG oligonucleotide prior to administration of the HIV antigen.
Patent EP-1198498-B1 (EP)
Inventor: CHAUDHARY BHARAT I
IPC: C08L75/04
Filed: 2000-06-15
Granted: 2004-05-12
Abstract: A closed-cell polymeric foam is provided which is formed using oil-containing furnace black as an insulation enhancer. Other foam properties (for example, cell sizes, densities, limiting oxygen index performance) are similar to those obtained with the use of thermal blacks.
Patent EP-1198585-B1 (EP)
Inventor: TRYON VICTOR
IPC: G16B25/10
Filed: 2000-06-28
Granted: 2007-06-13
Abstract: The invention provides a method, for evaluating a biological condition of a subject, comprising: a. obtaining from the subject a sample having at least one of RNAs and proteins; b. deriving from the sample a first profile data set, the first profile data set including a plurality of members, each member being a quantitative measure of the amount of a distinct RNA or protein constituent in a panel of constituents selected so that measurement of the constituents enables measurement of the biological condition; and c. producing a calibrated profile data set for the panel, wherein each member of the calibrated profile data set is a function of a corresponding member of the first profile data set and a corresponding member of a baseline profile data set for the panel, the calibrated profile data set providing a measure of the biological condition of the subject.
Patent EP-1200389-B1 (EP)
Inventor: BLAUFELDER CHRISTIAN
IPC: C07C229/12
Filed: 2000-07-06
Granted: 2004-09-22
Abstract: The invention relates to a process for preparing betaines of formula (I) wherein R<1 >represents a C1-C24 hydrocarbon group, and R<2 >and R<3 >independently represent a C1-C3 hydrocarbon group, comprising reacting an aqueous solution of an ethoxylated quaternay ammonium compound of formula (II) wherein R<1>, R<2>, and R<3 >have the same meaning as described above and X<-> represents a suitable anion, with oxygen or an oxygen-containing gas under alkaline conditions in the presence of a supported and promoted Pt catalyst at a temperature ranging from room temperature to 70° C. Preferably, use is made of a Pt/Bi/C catalyst. The invention process is particularly suitable for converting choline chloride into betaine, which is used as an animal feed
Patent EP-1188058-B1 (EP)
Inventor: HAEMAELAEINEN MAIKKU
IPC: G01N21/05
Filed: 2000-06-19
Granted: 2005-05-11
Abstract: A method and apparatus for assaying a drug candidate with a biosensor having one or more sensing surface-bound biomolecules associated therewith are disclosed. The method comprises the steps of measuring the binding interaction between the drug candidate and the one or more sensing surface-bound biomolecules of the biosensor to obtain an estimate of at least one binding interaction parameter of the drug candidate, and then comparing the estimated binding interaction parameter against a mathematical expression correlated from binding interaction data associated with known drug compounds to determine an estimate of at least pharmacokinetic parameter of absorption, distribution, metabolism, or excretion (ADME) that is related to the drug candidate. The present invention allows for the simultaneous measurement of different pharmacokinetic parameters of the drug candidate, as well as an indication of the drug candidate's solubility, by use of a single analytical instrument. The pharmacokinetic data may be represented as a ADME characterization profile; such ADME profiles are of great utility for purposes of drug screening and lead optimization.
Patent EP-1112566-B1 (EP)
Inventor: WUTTE HERIBERT
IPC: G10L15/06
Filed: 2000-07-07
Granted: 2005-10-05
Abstract: In a speech recognition device (1) comprising receiving means (36) for receiving voice information (AI) uttered by a speaker and including speech coefficient storage means (38, 39, 40, 41) for storing a speech coefficient indicator (SKI, PRI, SMI, WI) and including speech recognition means (42) which are arranged for recognizing text information (RTI) which corresponds to the received voice information (AI) by evaluating the voice information (AI) and the speech coefficient indicator (SKI, PRI, SMI, WI), transfer means (54) are now provided which enable to import a speech coefficient indicator (SKI, PRI, SMI, WI) and to store the imported speech coefficient indicator (SKI, PRI, SMI, WI) in the speech coefficient storage means (38, 39, 40, 41).
Patent EP-1222537-B1 (EP)
Inventor: BRANSILAV MEANDZIJA
IPC: G06F9/50
Filed: 2000-09-05
Granted: 2005-01-12
Abstract: A resource access control system that restricts access rights of individual software objects executing in a processing device. A software object is designated as belonging to one or more protection domains. Each protection domain defines permissions to resources accessible by a software object. Resource allocations for a software object can change over time, even while the object is executing. Another advantage that the present approach provides is that the consumer can download a software object with some of the object's functionality disabled via resource controls. Later, the same consumer can pay for additional functionality within the same software object. This is achieved by changing the resource control on the software object so that the software object can now access an expanded list of resources. Software objects are associated with a security group ID that associates the object with a particular protection domain.
Patent EP-1215994-B1 (EP)
Inventor: SLEPIAN MARVIN J
IPC: A61F2/82
Filed: 2000-09-15
Granted: 2007-07-25
Abstract: Implants, including sensors responsive to pressure, fluid flow, concentration of analytes, pH and other variables, including a feedback loop and means for modifying the implant after placement in a patient in response to measurements made using the sensors, have been developed. Feedback from the sensor(s) signal changes that may be required, such as expansion of the implant in the case where the vessel diameter changes over time or the implant becomes unstable or migrates. In another embodiment, the implant contains a bioactive, prophylactic, diagnostic or pH modifying agent wherein the implant is formed of a temperature or pH responsive material so that the agent is released when the temperature or pH is altered. These systems can also be used to connect a patient to a remote data storage system, such as the internet or a computer accessible through devices such as PDA (Palm Pilot systems), phone system devices, that the physician can use to interact remotely with the implant.
Patent EP-1207999-B1 (EP)
Inventor: FUNCK HANS-CHRISTOPH
IPC: B29D30/26
Filed: 2000-08-29
Granted: 2004-04-14
Abstract: The invention relates to a tyre building apparatus, whereby the press units (11, 12) are assembled in a pressing device (10), which can be displaced in the direction of the drum axis (30); said pressing units can be separated or brought together in a synchronous manner in relation to a central plane (M10) of the pressing device by means of a forced control device. The forced control device consists primarily of mechanical elements which are formed by threaded spindles (15, 16, 17) with parallel axes, whose ends have opposite thread pitches. The threaded spindles are axially fixed in a transfer ring (13) and are rotated by a synchronized drive. The pressing units (11, 12) are fitted with spindle nuts (22) which, in turn, engage with the ends of the threaded spindles (15, 16, 17). The forced control device is preferably driven by means of a servo-motor (20). The pressing device (10) is fitted with a  core-transfer device which is used to feed cores directly to the pressing units (11, 12).
Patent EP-1228154-B1 (EP)
Inventor: DAVIES MARTYN CHRISTOPHER
IPC: C09D143/02
Filed: 2000-10-16
Granted: 2004-05-26
Abstract: A polymer blend for use in a biomedical application comprising: (A) a polymer A, bearing zwitterionic pendant groups; and (B) a hydrophobic addition polymer B, selected from the group consisting silyl(alk)acrylates, alkyl(alk)acrylamides, dialkyl(alk)acrylamides, and alkyl(alk)acrylate polymers, wherein the structure of the blend exhibits phase separation forming a micro-phase segregated structure at a surface. Articles, methods of production and liquid blend compositions are also disclosed. Preferably A is a copolymer of 15 to 30 mole % 2-methacryloyloxyethy1-2-trimethylammonium ethyl phosphate inner salt and 85 to 70 mole % of a C<SUB>6-18 </SUB>alkyl methacrylate, and B is a homopolymer of a C<SUB>4-18 </SUB>alkyl(meth)acrylate, blended in weight proportions of 1:1 to 1:50.
Patent EP-1253649-B1 (EP)
Inventor: NAKATA JOSUKE
IPC: H01L33/36
Filed: 2000-10-20
Granted: 2008-07-16
Abstract: Dispositif à semi-conducteur (10) qui possède une fonction de réception de lumière et comporte un élément semi-conducteur (1) monocristallin en silicium de type p, des première et seconde faces plates (2, 7), une couche de diffusion (3) de type n, une jonction pn (4), une couche de recristallisation (8), un film antireflet (6a), une électrode négative (9a), et une électrode positive (9b). Un élément semi-conducteur à forme de colonne peut être utilisé à la place de l'élément semi-conducteur (1).
Patent EP-1226048-B1 (EP)
Title: Arrangement at a load carrier
Inventor: SANDSTROEM DAN
IPC: B62D33/04
Filed: 2000-11-01
Granted: 2007-04-04
Abstract: The present invention relates to a load carrier arrangement mounted in a loading compartment and comprising a pair of vertically disposed carrier rails (10) and a load carrier that extends between said rails and that includes at both ends slide shoes (16) that can be raised and lowered along the carrier rails. The carrier rails (10) include a longitudinally extending recess (12) in which runners (19) on the slide shoes (16) can run.
Patent EP-1230373-B1 (EP)
Inventor: BANAS ANTONI
IPC: C12N9/10
Filed: 2000-11-10
Granted: 2007-02-07
Abstract: The present invention relates to the use of a novel enzyme and its encoding gene for transformation. More specifically, the invention relates to the use of a gene encoding an enzyme with acyl-CoA: diacylglycerol acyltransferase activity. This gene expressed alone in transgenic organisms will increase the total amount of oil <i>i.e. triacylglycerols</i> that is produced.
Patent EP-1246988-B1 (EP)
Inventor: RETTIG REINHARD
IPC: E05B79/06
Filed: 2000-12-13
Granted: 2004-09-22
Abstract: The invention relates to a device for fixing an insert (10) in an opening of a carrier. The opening is defined by a and second carrier edge (21, 22). First and second edge areas (11, 12) appurtenant thereto and pertaining to the insert (10) are pressed against the opening in the case of fixing. According to the invention, the two edge areas of the insert (10) can be fixed essentially free from backlash and by means of a clamping device that consists of two clamping strips (60) which, preferably in a connected configuration, embrace the shell-shaped housing (13) in a waist-like manner.
Patent EP-1226487-B1 (EP)
Inventor: SMITH KIM
IPC: G06F3/0482
Filed: 2000-10-20
Granted: 2003-06-25
Abstract: A user interface, system, method and software for displaying a simulated three-dimensional display of menu options to a user, thereby maximizing use of a display's real estate by presenting all available options at once while at the same time presenting certain options in a more pronounced manner. The system monitors for running applications, polls the running applications for any available options, and displays the options in the simulated three-dimensional format. With this type of dynamic menu, standard means for bringing focus to a selectable target create complexities, and are thus avoided by designing the system's cursor to duplicate the appearance of the selected target's shape, preferably in a smaller size.
Patent EP-1331934-B1 (EP)
Inventor: KIPPENBERGER STEFAN
IPC: A61P17/00
Filed: 2000-11-09
Granted: 2006-03-29
Abstract: L'invention concerne des médicaments contenant des activateurs de récepteurs α, β (également connus comme δ) activés par des proliférateurs de peroxysome et servant au traitement de troubles cutanés dus à des maladies auto-immunitaires ou à des effets de rayonnement, par exemple, des rayons solaires, des rayons UV, des rayons X ou η. La présente invention porte également sur la suppression de réactions de rejet qu'un organisme récepteur développe contre des tissus transplantés, ainsi que sur l'utilisation desdits médicaments pour inhiber les phénomènes du vieillissement.
Patent EP-1203537-B1 (EP)
Inventor: ZITTEL DAVID R
IPC: A23N12/04
Filed: 2001-10-04
Granted: 2004-03-10
Abstract: A frameless food blancher has a steel tank (10) of generally U-shaped, transverse cross sectional shape and also has an open top with opposite sides. The opposite sides each have an upper edge (27) bent inwardly and downwardly to form an upwardly facing water trough (29). A rigidifying steel member (26) co-extensive in length with the trough is welded to it, and is also welded to the outer side of the tank. The trough and member form a cross section shape of triangular-box-cross-section and act to rigidify the sides. The blancher has opposite ends and an end plate (12, 13) is fabricated from sheet steel and has a main portion (17) welded to each of the opposite ends of the tank. These plates also each having a leg portion (18) integral with the main portion (17) for supporting the blancher. The end plates are formed by being cut by a CNC laser machine which simultaneously forms a series of holes extending through the end plate. A method of manufacturing the steel end plate for a food blancher, the end plate has a main portion for being welded to a tank end and an integral leg portion extending from the main portion. The method is accomplished by providing a steel sheet and automatically cutting out the main portion and the integral leg portion, and also substantially simultaneously locating and cutting holes in the end portion, all cutting being done automatically by a CNC laser machine. <IMAGE>